{"entity": "researcher", "timestamp": "2026-11-17T18:58:49.476Z", "family": "Mononen", "given": "Tommi", "initials": "T", "orcid": "0000-0002-3603-0813", "affiliations": ["Department of Computer Science, Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki 00014, Finland."], "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/researcher/bfaa4a59a9c84a7689eefa3763c6f338.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/researcher/bfaa4a59a9c84a7689eefa3763c6f338"}}, "publications": [{"entity": "publication", "iuid": "f7991bdd9b7144d3b8264ca177b1ee3e", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/f7991bdd9b7144d3b8264ca177b1ee3e.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/f7991bdd9b7144d3b8264ca177b1ee3e"}}, "title": "Understanding cellular growth strategies via optimal control.", "authors": [{"family": "Mononen", "given": "Tommi", "initials": "T", "orcid": "0000-0002-3603-0813", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/bfaa4a59a9c84a7689eefa3763c6f338.json"}}, {"family": "Kuosmanen", "given": "Teemu", "initials": "T", "orcid": "0000-0002-8724-5048", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/6cc757af21f644af8a2a4076b9a1af98.json"}}, {"family": "Cairns", "given": "Johannes", "initials": "J", "orcid": "0000-0003-1329-2025", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/98797bc481794a2396a5b6e857b636b3.json"}}, {"family": "Mustonen", "given": "Ville", "initials": "V", "orcid": "0000-0002-7270-1792", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/53f990a607764e3c9510317d558e2cd6.json"}}], "type": "journal article", "published": "2023-01-00", "journal": {"title": "J R Soc Interface", "issn": "1742-5662", "issn-l": null, "volume": "20", "issue": "198", "pages": "20220744"}, "abstract": "Evolutionary prediction and control are increasingly interesting research topics that are expanding to new areas of application. Unravelling and anticipating successful adaptations to different selection pressures becomes crucial when steering rapidly evolving cancer or microbial populations towards a chosen target. Here we introduce and apply a rich theoretical framework of optimal control to understand adaptive use of traits, which in turn allows eco-evolutionarily informed population control. Using adaptive metabolism and microbial experimental evolution as a case study, we show how demographic stochasticity alone can lead to lag time evolution, which appears as an emergent property in our model. We further show that the cycle length used in serial transfer experiments has practical importance as it may cause unintentional selection for specific growth strategies and lag times. Finally, we show how frequency-dependent selection can be incorporated to the state-dependent optimal control framework allowing the modelling of complex eco-evolutionary dynamics. Our study demonstrates the utility of optimal control theory in elucidating organismal adaptations and the intrinsic decision making of cellular communities with high adaptive potential.", "doi": "10.1098/rsif.2022.0744", "pmid": "36596459", "labels": {"Johannes Cairns": null, "DDLS Fellow": null}, "xrefs": [{"db": "pmc", "key": "PMC9810423"}, {"db": "figshare", "key": "10.6084/m9.figshare.c.6350197"}], "notes": [], "created": "2026-11-17T09:05:43.677Z", "modified": "2026-11-17T09:17:26.073Z"}, {"entity": "publication", "iuid": "7643571b6c5442cfa6991e22ab1dc2e6", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/7643571b6c5442cfa6991e22ab1dc2e6.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/7643571b6c5442cfa6991e22ab1dc2e6"}}, "title": "Drug-induced resistance evolution necessitates less aggressive treatment.", "authors": [{"family": "Kuosmanen", "given": "Teemu", "initials": "T", "orcid": "0000-0002-8724-5048", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/6cc757af21f644af8a2a4076b9a1af98.json"}}, {"family": "Cairns", "given": "Johannes", "initials": "J", "orcid": "0000-0003-1329-2025", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/98797bc481794a2396a5b6e857b636b3.json"}}, {"family": "Noble", "given": "Robert", "initials": "R", "orcid": "0000-0002-8057-4252", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/4af492853ab1474ab917ebb9fec45058.json"}}, {"family": "Beerenwinkel", "given": "Niko", "initials": "N", "orcid": "0000-0002-0573-6119", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/ae64bd2591e4423da28c66e4eeebd31e.json"}}, {"family": "Mononen", "given": "Tommi", "initials": "T", "orcid": "0000-0002-3603-0813", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/bfaa4a59a9c84a7689eefa3763c6f338.json"}}, {"family": "Mustonen", "given": "Ville", "initials": "V", "orcid": "0000-0002-7270-1792", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/53f990a607764e3c9510317d558e2cd6.json"}}], "type": "journal article", "published": "2021-09-00", "journal": {"title": "PLoS Comput Biol", "issn": "1553-7358", "issn-l": "1553-734X", "volume": "17", "issue": "9", "pages": "e1009418"}, "abstract": "Increasing body of experimental evidence suggests that anticancer and antimicrobial therapies may themselves promote the acquisition of drug resistance by increasing mutability. The successful control of evolving populations requires that such biological costs of control are identified, quantified and included to the evolutionarily informed treatment protocol. Here we identify, characterise and exploit a trade-off between decreasing the target population size and generating a surplus of treatment-induced rescue mutations. We show that the probability of cure is maximized at an intermediate dosage, below the drug concentration yielding maximal population decay, suggesting that treatment outcomes may in some cases be substantially improved by less aggressive treatment strategies. We also provide a general analytical relationship that implicitly links growth rate, pharmacodynamics and dose-dependent mutation rate to an optimal control law. Our results highlight the important, but often neglected, role of fundamental eco-evolutionary costs of control. These costs can often lead to situations, where decreasing the cumulative drug dosage may be preferable even when the objective of the treatment is elimination, and not containment. Taken together, our results thus add to the ongoing criticism of the standard practice of administering aggressive, high-dose therapies and motivate further experimental and clinical investigation of the mutagenicity and other hidden collateral costs of therapies.", "doi": "10.1371/journal.pcbi.1009418", "pmid": "34555024", "labels": {"Johannes Cairns": null, "DDLS Fellow": null}, "xrefs": [{"db": "pmc", "key": "PMC8491903"}, {"db": "pii", "key": "PCOMPBIOL-D-21-00207"}], "notes": [], "created": "2026-11-17T09:06:30.433Z", "modified": "2026-11-17T09:18:14.685Z"}, {"entity": "publication", "iuid": "29393f3a9286457bb8adce9668d29585", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/29393f3a9286457bb8adce9668d29585.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/29393f3a9286457bb8adce9668d29585"}}, "title": "Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression.", "authors": [{"family": "Anttila", "given": "Jani V", "initials": "JV", "orcid": "0000-0002-2102-1930", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/e88a8a60c8574f6b93c353755060cb46.json"}}, {"family": "Shubin", "given": "Mikhail", "initials": "M", "orcid": "0000-0002-0677-6761", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/81a5c6d13e11407084fcaa650912d222.json"}}, {"family": "Cairns", "given": "Johannes", "initials": "J", "orcid": "0000-0003-1329-2025", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/98797bc481794a2396a5b6e857b636b3.json"}}, {"family": "Borse", "given": "Florian", "initials": "F"}, {"family": "Guo", "given": "Qingli", "initials": "Q"}, {"family": "Mononen", "given": "Tommi", "initials": "T", "orcid": "0000-0002-3603-0813", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/bfaa4a59a9c84a7689eefa3763c6f338.json"}}, {"family": "V\u00e1zquez-Garc\u00eda", "given": "Ignacio", "initials": "I", "orcid": "0000-0003-0427-2639", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/11c54cbf1aca4746afebbf0f3caf848f.json"}}, {"family": "Pulkkinen", "given": "Otto", "initials": "O", "orcid": "0000-0001-5739-6278", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/7bb0c87d9626432baa8c066398bb61d7.json"}}, {"family": "Mustonen", "given": "Ville", "initials": "V", "orcid": "0000-0002-7270-1792", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/53f990a607764e3c9510317d558e2cd6.json"}}], "type": "journal article", "published": "2019-11-00", "journal": {"title": "PLoS Comput Biol", "issn": "1553-7358", "issn-l": "1553-734X", "volume": "15", "issue": "11", "pages": "e1007493"}, "abstract": "A tumour grows when the total division (birth) rate of its cells exceeds their total mortality (death) rate. The capability for uncontrolled growth within the host tissue is acquired via the accumulation of driver mutations which enable the tumour to progress through various hallmarks of cancer. We present a mathematical model of the penultimate stage in such a progression. We assume the tumour has reached the limit of its present growth potential due to cell competition that either results in total birth rate reduction or death rate increase. The tumour can then progress to the final stage by either seeding a metastasis or acquiring a driver mutation. We influence the ensuing evolutionary dynamics by cytotoxic (increasing death rate) or cytostatic (decreasing birth rate) therapy while keeping the effect of the therapy on net growth reduction constant. Comparing the treatments head to head we derive conditions for choosing optimal therapy. We quantify how the choice and the related gain of optimal therapy depends on driver mutation, metastasis, intrinsic cell birth and death rates, and the details of cell competition. We show that detailed understanding of the cell population dynamics could be exploited in choosing the right mode of treatment with substantial therapy gains.", "doi": "10.1371/journal.pcbi.1007493", "pmid": "31738747", "labels": {"Johannes Cairns": null, "DDLS Fellow": null}, "xrefs": [{"db": "pmc", "key": "PMC6886869"}, {"db": "pii", "key": "PCOMPBIOL-D-19-00706"}], "notes": [], "created": "2026-11-17T09:06:36.207Z", "modified": "2026-11-17T09:18:34.636Z"}]}